Spinal cord ischemia/injury. 2014

T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh

A spinal cord injury leads to disturbances of sensory and motor signals due to the damage to white matter and myelinated fiber tracts. Moreover, the damage to gray matter causes segmental loss of interneurons of dorsal horn and motoneurons and restricts the therapeutic options. Neuroprotective strategies have the potential to improve the neurological outcome of patients. To achieve this, concerns to anesthetics or analgesics as neuroprotective interventions have been accumulating to explore neuroprotection during perioperative period. This review includes consideration of: 1) basic concepts of the pathophysiological mechanisms following spinal cord injury and 2) anesthetics and analgesics displaying neuroprotective potential. In particular, we review the application of isoflurane as an inhalational neuroprotectant and discuss evidence for the neuroprotection provided by barbiturates. In addition, 3) recent advances in stem cell biology, neural injury and repair, and progress toward the development of neuroprotective and regenerative interventions are the basis for increased optimism.

UI MeSH Term Description Entries
D007530 Isoflurane A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
D012038 Regeneration The physiological renewal, repair, or replacement of tissue. Endogenous Regeneration,Regeneration, Endogenous,Regenerations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000777 Anesthetics Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. Anesthetic,Anesthetic Agents,Anesthetic Drugs,Anesthetic Effect,Anesthetic Effects,Agents, Anesthetic,Drugs, Anesthetic,Effect, Anesthetic,Effects, Anesthetic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013119 Spinal Cord Injuries Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.). Myelopathy, Traumatic,Injuries, Spinal Cord,Post-Traumatic Myelopathy,Spinal Cord Contusion,Spinal Cord Laceration,Spinal Cord Transection,Spinal Cord Trauma,Contusion, Spinal Cord,Contusions, Spinal Cord,Cord Contusion, Spinal,Cord Contusions, Spinal,Cord Injuries, Spinal,Cord Injury, Spinal,Cord Laceration, Spinal,Cord Lacerations, Spinal,Cord Transection, Spinal,Cord Transections, Spinal,Cord Trauma, Spinal,Cord Traumas, Spinal,Injury, Spinal Cord,Laceration, Spinal Cord,Lacerations, Spinal Cord,Myelopathies, Post-Traumatic,Myelopathies, Traumatic,Myelopathy, Post-Traumatic,Post Traumatic Myelopathy,Post-Traumatic Myelopathies,Spinal Cord Contusions,Spinal Cord Injury,Spinal Cord Lacerations,Spinal Cord Transections,Spinal Cord Traumas,Transection, Spinal Cord,Transections, Spinal Cord,Trauma, Spinal Cord,Traumas, Spinal Cord,Traumatic Myelopathies,Traumatic Myelopathy
D018685 Anesthetics, Inhalation Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) Inhalation Anesthetic,Inhalation Anesthetics,Anesthetic Gases,Anesthetic, Inhalation,Gases, Anesthetic
D018696 Neuroprotective Agents Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. Neuroprotectant,Neuroprotective Agent,Neuroprotective Drug,Neuroprotectants,Neuroprotective Drugs,Neuroprotective Effect,Neuroprotective Effects,Agent, Neuroprotective,Agents, Neuroprotective,Drug, Neuroprotective,Drugs, Neuroprotective,Effect, Neuroprotective,Effects, Neuroprotective
D020760 Spinal Cord Ischemia Reduced blood flow to the spinal cord which is supplied by the anterior spinal artery and the paired posterior spinal arteries. This condition may be associated with ARTERIOSCLEROSIS, trauma, emboli, diseases of the aorta, and other disorders. Prolonged ischemia may lead to INFARCTION of spinal cord tissue. Experimental Spinal Cord Ischemia,Ischemic Myelopathy,Spinal Cord Ischemia, Experimental,Cord Ischemia, Spinal,Cord Ischemias, Spinal,Ischemia, Spinal Cord,Ischemias, Spinal Cord,Ischemic Myelopathies,Myelopathies, Ischemic,Myelopathy, Ischemic,Spinal Cord Ischemias

Related Publications

T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
May 1971, Journal of neurosurgery,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
November 2013, The International journal of neuroscience,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
January 2021, Neuromodulation : journal of the International Neuromodulation Society,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
November 2022, Basic research in cardiology,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
March 2021, Der Radiologe,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
January 2004, Journal of neuroradiology = Journal de neuroradiologie,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
November 2020, Neural regeneration research,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
July 2015, The Annals of thoracic surgery,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
April 2015, Journal of cardiothoracic and vascular anesthesia,
T Ishikawa, and H Suzuki, and K Ishikawa, and S Yasuda, and T Matsui, and M Yamamoto, and T Kakeda, and S Yamamoto, and Y Owada, and T L Yaksh
November 2001, FEBS letters,
Copied contents to your clipboard!